Trial Profile

A Phase 1, two-part EEG clinical trial evaluating the safety, tolerability, pharmacokinetics and pharmacodynamics of PRAX-562 in Healthy Volunteers

Status: Completed

Phase of Trial: Phase I

Latest Information Update: 04 Sep 2023

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

31 Aug 2023 According to a Praxis Precision Medicines media release, data from this trial will be presented at the upcoming 35th International Epilepsy Congress (IEC) 2023.
11 May 2023 According to a Praxis Precision Medicines media release, results findings from this trial presented in a poster presentation at the 75th Annual American Academy of Neurology (AAN) meeting in Apr 2023.
27 Apr 2023 Results presented at the 75th Annual Meeting of the American Academy of Neurology 2023

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com